Jacobs Levy Equity Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-69,851
Closed -$405K 1111
2023
Q1
$405K Sell
69,851
-67,794
-49% -$586K ﹤0.01% 826
2022
Q4
$1.09M Sell
137,645
-109,835
-44% -$471K 0.01% 665
2022
Q3
$782K Buy
247,480
+84,499
+52% +$529K 0.01% 760
2022
Q2
$934K Buy
+162,981
New +$1.27M 0.01% 768

Other funds holding ICVX

Jacobs Levy Equity Management's ICVX Position: Q2 2023 in Review

Jacobs Levy Equity Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q2 2023, closing a stake of 69,851 shares — an estimated $405K sold.

Jacobs Levy Equity Management first reported a position in ICVX in Q2 2022 and held it in 4 quarters. The position peaked at $1.09M in Q4 2022. 62 funds tracked by Wall St. Rank hold ICVX as of Q2 2023.

  • Jacobs Levy Equity Management reported no remaining Icosavax, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 69,851 Icosavax, Inc. Common Stock shares in Q2 2023, an estimated $405K.
  • Jacobs Levy Equity Management first reported a position in Icosavax, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Jacobs Levy Equity Management's Icosavax, Inc. Common Stock position peaked at $1.09M in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q2 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.